- Home
- GXAI vs ISPC Comparison
GXAI vs ISPC Comparison
Compare GXAI & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- ISPC
- Stock Information
- Founded
- GXAI 2021
- ISPC 2009
- Country
- GXAI United States
- ISPC United States
- Employees
- GXAI N/A
- ISPC N/A
- Industry
- GXAI
- ISPC Precision Instruments
- Sector
- GXAI
- ISPC Health Care
- Exchange
- GXAI Nasdaq
- ISPC Nasdaq
- Market Cap
- GXAI 13.0M
- ISPC 13.9M
- IPO Year
- GXAI 2023
- ISPC 2021
- Fundamental
- Price
- GXAI $1.85
- ISPC $0.81
- Analyst Decision
- GXAI
- ISPC
- Analyst Count
- GXAI 0
- ISPC 0
- Target Price
- GXAI N/A
- ISPC N/A
- AVG Volume (30 Days)
- GXAI 416.9K
- ISPC 1.0M
- Earning Date
- GXAI 11-13-2025
- ISPC 11-06-2025
- Dividend Yield
- GXAI N/A
- ISPC N/A
- EPS Growth
- GXAI N/A
- ISPC N/A
- EPS
- GXAI N/A
- ISPC N/A
- Revenue
- GXAI $198,711.00
- ISPC $5,908,088.00
- Revenue This Year
- GXAI N/A
- ISPC $35.93
- Revenue Next Year
- GXAI N/A
- ISPC N/A
- P/E Ratio
- GXAI N/A
- ISPC N/A
- Revenue Growth
- GXAI 72158.55
- ISPC N/A
- 52 Week Low
- GXAI $1.00
- ISPC $0.64
- 52 Week High
- GXAI $7.50
- ISPC $8.30
- Technical
- Relative Strength Index (RSI)
- GXAI 53.25
- ISPC 37.89
- Support Level
- GXAI $1.80
- ISPC $0.78
- Resistance Level
- GXAI $2.07
- ISPC $0.89
- Average True Range (ATR)
- GXAI 0.17
- ISPC 0.10
- MACD
- GXAI 0.01
- ISPC -0.05
- Stochastic Oscillator
- GXAI 49.17
- ISPC 7.42
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.